Group 1: Financial Performance - In Q1 2025, the company's revenue reached ¥588,046,436.78, an increase of 14.85% year-on-year [3] - Net profit attributable to shareholders was ¥25,213,223.30, up 563.86% compared to the same period last year [3] - The net profit excluding non-recurring items was ¥20,230,280.30, reflecting a 733.88% increase year-on-year [3] - Basic earnings per share rose to ¥0.0542, marking a 470.53% increase from the previous year [3] Group 2: Business Strategy and Operations - The company is optimizing its business structure and reducing production costs to improve competitiveness in the new energy materials sector [2] - Continuous investment in R&D and market expansion is planned to enhance the leading position in specialized products [2] - The production capacity for lithium sulfide solid-state battery materials is currently 300 tons/year, with ongoing customer validation [3] Group 3: Risk Management and Financial Health - The company generates approximately ¥300 million in operating cash flow and has a balanced distribution of financing due in 2025, averaging around ¥100 million per month [3] - The company has made a provision for impairment of ¥139.7 million in 2024 for the new energy materials sector, reflecting concerns over the ongoing low prices of lithium carbonate [3] Group 4: Market Trends and Competitive Landscape - PCB chemical revenue grew by 20.23%, accounting for 63.5% of total revenue, amidst a backdrop of accelerated domestic substitution [4] - The electronic chemicals industry is expected to benefit from emerging technologies and government support, indicating a positive outlook for future growth [5] - The company is focused on overcoming challenges in high-end PCB chemicals, which still rely on over 30% imports [4]

Summary of Guanghua Technology Conference Call Company Overview - Guanghua Technology reported strong Q1 performance driven by record sales in PCB chemicals and chemical reagents, while losses in the new energy sector were effectively controlled, laying a solid foundation for annual performance [2][4] Key Points Industry and Business Segments - The company operates in three main segments: chemical reagents, PCB electronic chemicals, and new energy materials, with the new energy materials further divided into green materials and tiered products [10] - The lithium battery business includes lithium battery materials, green ring materials, and retired battery processing, with a focus on high-profit projects to significantly improve gross margins [2][9] Strategic Adjustments - The new energy segment is undergoing strategic adjustments, with high-value lithium iron phosphate production remaining in Guangdong, while other lithium iron phosphate and recycling products are planned to be relocated to cost-effective regions like Dazhou, Sichuan [3][13] - The company plans to relocate its new energy production base to Dazhou to leverage local cost advantages in electricity, natural gas, and phosphoric acid, while enhancing collaboration with major clients like Honeycomb and CATL [2][6][7] Financial Performance and Projections - Despite a revenue decline in 2025 due to price and demand factors, the company is proactively reducing unprofitable orders, leading to improved profitability in PCB electronic chemicals, with expectations of double-digit growth in the next one to two years [2][12][21] - A new project for 49,000 tons of specialized chemical materials is planned, including 39,000 tons of chemical reagents and 10,000 tons of PCB electronic chemicals, projected to generate annual revenue of approximately 800 million yuan and a gross profit of about 200 million yuan [2][20] Product Development and Market Position - The company is focusing on high-value products such as lithium manganese iron phosphate and lithium sulfide, with plans to develop high-purity chemical reagents for import substitution, achieving gross margins of over 40% [5][14][25] - The green ring materials segment has improved gross margins by focusing on profitable projects and reducing unprofitable orders, with a strategy to continue optimizing this approach [14] Challenges and Competitive Landscape - The chemical reagent segment faces intense competition, but the company has a strong advantage in import substitution due to significant R&D investment and a robust development model that involves direct collaboration with industry leaders [27][28] - The company has over 200 R&D personnel who engage directly with clients' R&D teams to identify and develop products for import substitution, enhancing efficiency and product quality [28] Future Outlook - The company expects double-digit growth in the chemical reagents and electronic chemicals segments, while the new energy segment is not anticipated to grow due to the ongoing relocation plans [19] - The company is also exploring opportunities in the pharmaceutical sector, aiming for high gross margins through collaboration with benchmark clients [25] Additional Insights - The company is currently in discussions regarding the Dazhou project, which is still in the early communication phase with partners and stakeholders [8] - The current production capacity for various products is as follows: chemical reagents at approximately 30,000 tons, PCB electronic chemicals at over 60,000 tons with an 80% utilization rate, and new energy materials at about 10% due to the relocation [18]

Group 1 - Shenjian Co., Ltd. reported a net profit of 33.65 million yuan for 2024, a year-on-year increase of 32.29%, with a proposed cash dividend of 0.5 yuan per 10 shares [1] - Jingce Electronics experienced a net loss of 97.60 million yuan in 2024, transitioning from profit to loss, despite a revenue increase of 5.59% to 2.565 billion yuan [1] - Jingwei Co., Ltd. reported a net profit of 35.54 million yuan for 2024, a decrease of 36.76%, with a proposed cash dividend of 1.00 yuan per 10 shares [1][2] Group 2 - Minsheng Health achieved a net profit of 91.83 million yuan in 2024, a year-on-year increase of 7.24%, with a proposed cash dividend of 1.00 yuan per 10 shares [2] - Zhongshe Co., Ltd. reported a net profit of 10.16 million yuan for 2024, a decline of 76.24%, with a proposed cash dividend of 0.2 yuan per 10 shares [3] - Keyuan Smart reported a net profit of 252 million yuan for 2024, a year-on-year increase of 56.64%, with a proposed cash dividend of 0.4 yuan per 10 shares [4] Group 3 - Beilu Pharmaceutical reported a net profit of 14.54 million yuan for Q1 2025, a year-on-year increase of 26.13%, with revenue of 283 million yuan [5] - Wangsu Technology achieved a net profit of 192 million yuan for Q1 2025, a year-on-year increase of 38.54%, with revenue of 1.235 billion yuan [6] - Keyuan Pharmaceutical reported a net profit of 23.08 million yuan for Q1 2025, a year-on-year increase of 7.25%, despite a revenue decline of 23.98% [7] Group 4 - Guangting Information reported a net profit of 24.03 million yuan for Q1 2025, turning from loss to profit, with revenue of 134 million yuan [9] - Zhaori Technology reported a net loss of 1.23 million yuan for Q1 2025, with revenue of 35.23 million yuan [11] - Huakai Yibai reported a net loss of 15.09 million yuan for Q1 2025, despite revenue growth of 35.08% to 2.292 billion yuan [13] Group 5 - Xinhongye reported a net profit of 34.43 million yuan for Q1 2025, a year-on-year increase of 20.43%, with revenue of 755 million yuan [15] - Huning Co., Ltd. reported a net profit of 3.61 million yuan for Q1 2025, a year-on-year decrease of 45.68%, with revenue of 64.51 million yuan [16] - Camel Co., Ltd. reported a net profit of 237 million yuan for Q1 2025, a year-on-year increase of 51.89%, with revenue of 4.136 billion yuan [17] Group 6 - Hengtong Co., Ltd. reported a net profit of 42.55 million yuan for Q1 2025, a year-on-year increase of 51.62%, with revenue of 313 million yuan [19] - Changqing Technology reported a net profit of 35.38 million yuan for Q1 2025, a year-on-year decrease of 23.80%, with revenue of 246 million yuan [21] - Libaba Co., Ltd. reported a net profit of 34.72 million yuan for Q1 2025, a year-on-year increase of 9.91%, with revenue of 419 million yuan [22] Group 7 - Shouxiangu reported a net profit of 58.37 million yuan for Q1 2025, a year-on-year decrease of 24.32%, with revenue of 171 million yuan [24] - Bojun Technology announced a stock issuance application accepted by the Shenzhen Stock Exchange [24] - Dayou Energy announced the full resumption of production at its Gengcun coal mine, with an annual production capacity of 3.6 million tons [25] Group 8 - Deyang Co., Ltd. successfully acquired land use rights for industrial land in Ningbo for 45.80 million yuan [27] - Tianyu Pharmaceutical's subsidiary received a drug registration certificate for an injectable product [29] - Xingwang Yuda signed a strategic cooperation agreement with the Jilin Province Bionic Robot Innovation Center [30] Group 9 - Lifang Pharmaceutical received approval for clinical trials of a new drug [32] - Zai Sheng Technology reported a net profit of 33.56 million yuan for Q1 2025, a year-on-year increase of 3.69%, with revenue of 324 million yuan [34] - Jinxin Technology reported a net profit of 319,920 yuan for Q1 2025, turning from loss to profit, with revenue of 563 million yuan [36] Group 10 - Huayin Electric reported a net profit of 75.67 million yuan for Q1 2025, a year-on-year increase of 894.61%, with revenue of 2.307 billion yuan [37] - Xinghua Co., Ltd. reported a net loss of 95.51 million yuan for Q1 2025, with revenue of 840 million yuan [38] - Heren Technology reported a net loss of 384,410 yuan for Q1 2025, with revenue of 78.40 million yuan [40] Group 11 - Fenda Technology reported a net profit of 40.45 million yuan for Q1 2025, a year-on-year increase of 84.07%, with revenue of 760 million yuan [41] - Tongda Co., Ltd. reported a net profit of 25.49 million yuan for 2024, a year-on-year decrease of 69.15%, with revenue of 6.201 billion yuan [43] - Zhonghe Holdings reported a net profit of 283 million yuan for 2024, a year-on-year decrease of 54.69%, with a proposed cash dividend of 0.3 yuan per 10 shares [44] Group 12 - Jiantou Energy reported a net profit of 531 million yuan for 2024, a year-on-year increase of 181.59%, with a proposed cash dividend of 1.3 yuan per 10 shares [44] - Guanghua Technology reported a net loss of 205 million yuan for 2024, with revenue of 2.589 billion yuan [45] - Huajin Technology reported a net profit of 29.26 billion yuan for 2024, a year-on-year increase of 8.1%, with a proposed cash dividend of 9 yuan per 10 shares [46] Group 13 - Yingke Medical reported a net profit of 1.465 billion yuan for 2024, a year-on-year increase of 282.63%, with a proposed cash dividend of 1.00 yuan per 10 shares [46] - Solar Energy reported a net profit of 1.225 billion yuan for 2024, a year-on-year decrease of 22.38%, with a proposed cash dividend of 0.56 yuan per 10 shares [46] - Dongfang Electric reported a net profit of 318 million yuan for 2024, a year-on-year decrease of 50.62%, with a proposed cash dividend of 0.32 yuan per 10 shares [47] Group 14 - Tianneng Heavy Industry reported a net loss of 262 million yuan for 2024, with revenue of 3.273 billion yuan [48] - Gangyan High-tech reported a net profit of 249 million yuan for 2024, a year-on-year decrease of 22.08%, with a proposed cash dividend of 1.00 yuan per 10 shares [48] - Shihua Machinery reported a net profit of 96.88 million yuan for 2024, a year-on-year increase of 5.35%, with revenue of 8.037 billion yuan [49] Group 15 - Gongtong Pharmaceutical reported a net loss of 27.59 million yuan for 2024, with revenue of 537 million yuan [51] - Zhongjing Electronics reported a net loss of 87.43 million yuan for 2024, with revenue of 2.932 billion yuan [53] - Yudai Development reported a net loss of 114 million yuan for 2024, with revenue of 388 million yuan [55] Group 16 - Zhenhua Technology reported a net profit of 970 million yuan for 2024, a year-on-year decrease of 63.83%, with a proposed cash dividend of 1.8 yuan per 10 shares [56] - Jierong Technology reported a net loss of 298 million yuan for 2024, with revenue of 1.357 billion yuan [58] - Changgao Electric New reported a net profit of 252 million yuan for 2024, a year-on-year increase of 45.66%, with a proposed cash dividend of 0.8 yuan per 10 shares [60] Group 17 - Shibao Detection announced a plan to acquire 81% of Zhonghuan Lianshu for 52.65 million yuan [61] - Jiangsu Boyun announced a plan to reduce its shareholding by up to 3% [62] - Jingfeng Mingyuan announced a plan to acquire 100% of Yichong Technology for 3.283 billion yuan [63]

Investment Rating - The report maintains a "Buy" rating for the company, with an upward adjustment in profit forecasts for 2025-2027 [5][14]. Core Insights - The company reported a revenue of 2.589 billion RMB in 2024, a decline of 4% year-on-year, while the net profit attributable to shareholders was a loss of 205 million RMB, showing significant improvement compared to the previous year [2]. - In Q1 2025, the company achieved a revenue of 588 million RMB, marking a 15% increase year-on-year, with a net profit of 25 million RMB, a remarkable growth of 564% [2]. - The PCB chemicals and chemical reagents segments showed improved profitability, with PCB chemicals revenue growing by 20% to 1.64 billion RMB and a gross margin increase of 1.04 percentage points [3]. - The company plans to optimize its production layout and strengthen cooperation across the supply chain to enhance competitiveness in the new energy materials sector, which has been adversely affected by industry cycles [3][4]. Summary by Sections Financial Performance - The company’s revenue for 2024 was 2.589 billion RMB, with a projected increase to 3.007 billion RMB in 2025, reflecting a growth rate of 16.14% [10]. - The net profit is expected to recover to 110 million RMB in 2025, with further growth to 151 million RMB in 2026 and 187 million RMB in 2027 [10]. Business Segments - The PCB chemicals segment is a key growth driver, with a revenue increase of 20% in 2024, while the lithium battery materials segment faced challenges, with a 55% revenue decline [3]. - The company is reallocating 280 million RMB from the terminated high-performance lithium battery materials project to a new specialized chemical materials project, aimed at enhancing production capabilities in various industries [4]. Profitability and Valuation - The report projects net profits of 1.1 billion RMB and 1.51 billion RMB for 2025 and 2026, respectively, with a new forecast for 2027 at 1.87 billion RMB [5]. - The price-to-earnings (P/E) ratios for 2025-2027 are estimated at 66.25, 48.25, and 38.87 times, respectively [5].

Core Viewpoint - Solid-state battery additives are crucial materials for enhancing battery performance, such as ionic conductivity and interface stability, with a comprehensive ranking based on technology routes, production capacity, and market performance. Group 1: LiFSI (Lithium bis(fluorosulfonyl)imide) Sector - Ruifai New Materials ranks among the top three global LiFSI producers, with a production capacity exceeding 10,000 tons by 2025, suitable for high-voltage solid-state battery requirements. The purity reaches 99.9%, and costs are 15% lower than traditional lithium hexafluorophosphate. The company has supplied to CATL and BYD for solid-state battery projects [1]. - Limin Co., Ltd. has extended its technology through its subsidiary Zhuobang New Energy, ranking among the top three in LiFSI production capacity, suitable for high-safety scenarios like robotics and flying cars [2]. - The customer network of Limin Co., Ltd. includes leading battery companies such as CATL and Tesla, with overseas orders expected to grow by 85% in 2024 [3]. Group 2: Sulfide Electrolyte Precursors - Tianci Materials is the largest electrolyte liquid company globally, extending LiFSI technology to sulfide electrolyte precursors, with costs 44% lower than Japanese competitors. By 2025, LiFSI production capacity will expand to 20,000 tons, supporting sulfide all-solid-state battery production lines [5]. - Tianci Materials holds over 60% market share in the global sulfide precursor market, with a binding relationship with Yunnan Germanium for raw materials. The ionic conductivity of sulfide electrolytes reaches 10 mS/cm, with costs 40% lower than similar Japanese products [5]. - The market share of zirconium oxychloride exceeds 50%, compatible with both oxide and sulfide dual technology routes, with samples sent to leading companies like Qingtai Energy. By 2025, zirconium-based material production capacity will reach 20,000 tons, covering key raw material needs for electrolytes [5]. Group 3: Chlorosulfonic Acid (LiFSI Raw Material) - Shilong Industrial has a cost advantage, with chlorosulfonic acid production costs 20% lower than the industry average, having entered the supply chains of Tianci Materials and Ruifai New Materials [6]. Group 4: Other Key Additives - Longpan Technology and Aoke Co., Ltd. have achieved a production capacity of 5,000 tons/year for solvent-based additives for solid-state batteries, suitable for optimizing sulfide electrolyte interfaces [7]. Group 5: Potential Enterprises - Daoshi Technology is focusing on conductive agents (carbon nanotubes) and silicon-carbon negative electrode additives, catering to the high energy density requirements of solid-state batteries [8]. - Guanghua Technology is developing lithium salts (LiTFSI) and composite additives to enhance the cycle life of solid-state batteries [9]. Group 6: Industry Leaders - Kaisheng New Materials is the largest chlorosulfonic acid supplier globally, with a production capacity exceeding 100,000 tons/year and a market share over 40%. The purity reaches electronic grade (99.999%), suitable for solid-state battery electrolyte synthesis [12]. - The company possesses a technical barrier, being one of the few globally to master full-solid-state compatible additive technology, with a projected market share growth to 18% in 2024. Key clients include CATL and Tesla, with plans to double production capacity by 2025 [13].

事件 2025 年 4 月 23 日公司发布了 2024 年报和 2025 年 1 季报，公司 2024 年营业收入为 25.89 亿元，同比下滑 4%，归母净利润为亏损 2.05 亿元，同比大幅减亏；2025 年 1 季度营业收入为 5.88 亿元， 同比增长 15%，归母净利润为 0.25 亿元，同比增长 564%。 经营分析 PCB 化学品和化学试剂盈利改善，新能源材料有望优化实现减亏。 从公司分板块业务表现来看，2024 年 PCB 化学品和化学试剂收入 增长且盈利提升，PCB 化学品收入同比增长 20%达到 16.4 亿元， 毛利率同比提高 1.04pct，化学试剂收入同比增长 7%达到 4.7 亿 元，毛利率同比提高 4.09pct；受行业周期影响，新能源材料订单 需求不足且碳酸锂等产品价格持续低位，板块获利能力继续下降 导致经营亏损，2024 年锂电池材料收入同比下滑 55%至 2.6 亿元， 毛利率同比下滑 18.55pct。面对新能源材料行业周期性波动对经 营产生的不利影响，公司计划通过合理调整生产基地的布局，进一 步强化产业链上下游稳定协同合作关系，对产业链进行优化降本， 提高公司新能源产 ...

广东光华科技股份有限公司 董事会审计委员会对会计师事务所 2024 年度履职情况的评估报告 根据《公司法》、《证券法》、《上市公司治理准则》、《国有企业、上市公司选 聘会计师事务所管理办法》等规定和要求，广东光华科技股份有限公司（以下简 称"公司"）对公司 2024 年审计机构众华会计师事务所（特殊普通合伙）（以下简 称"众华会计师事务所"）的履职情况进行了评估。现将评估情况报告如下： 一、会计师事务所基本情况 （一）资质条件 众华会计师事务所(特殊普通合伙)成立于 1985 年 9 月，是在上海注册的中国 大型会计师事务所之一，原名上海众华沪银会计师事务所，于 2013 年 12 月转制 为特殊普通合伙事务所，事务所更名为：众华会计师事务所（特殊普通合伙）。 公司于 2024 年 4 月 26 日召开第五届董事会第十二次会议、第五届监事会第 十一次会议，审议通过了《关于续聘会计师事务所的议案》的议案，同意续聘众 华会计师事务所(特殊普通合伙)为公司 2024 年度审计机构。上述议案于 2024 年 5 月 17 日经公司召开 2023 年度股东大会审议通过。 二、会计师事务所 2024 年度审计履职情况 按 ...

2024 年年度监事会工作报告 2024 年年度，公司监事会全体成员本着对全体股东负责的精神，在董事会及 各级领导的支持和配合下，严格按照《公司法》、《公司章程》和公司《监事会议 事规则》等法律法规及规章制度的规定，依法独立行使职权，积极有效地开展工 作，了解和掌握公司的生产经营决策情况，对公司依法运作情况和公司董事、高 级管理人员履行职责情况进行监督，维护了公司及股东的合法权益。现将 2024 年 度主要工作分述如下： 一、2024 年度监事会的工作情况： 报告期内，公司监事会共召开 4 次会议，具体情况如下： 1、2024 年 4 月 26 日，公司召开第五届监事会第十一次会议，本次会议应到 监事 3 人，实到监事 3 人，会议审议通过了以下议案： （1）《2023 年年度报告及摘要》； （2）《2023 年年度监事会工作报告》； 广东光华科技股份有限公司 （3）《2023 年年度财务决算报告》； （4）《2023 年度利润分配预案》； （5）《2023 年年度内部控制自我评价报告》； （6）《关于公司 2024 年度向银行申请办理综合授信业务并提供担保的议案》； （7）《关于公司<未来三年股东回报规划（ ...

证券代码：002741 证券简称：光华科技 公告编号：2025-021 为满足公司及下属子公司经营及发展的需要，2025 年度公司拟在全资子、 孙公司申请信贷业务及日常经营需要时为其提供对外担保，担保额度不超过人民 币 4.5 亿元，被担保的全资子公司包括：广州市金华大化学试剂有限公司、广东 东硕科技有限公司、广东光华科技股份（香港）有限公司、光华科学技术研究院 （广东）有限公司、海南中力焕能新能源科技有限公司共五家子公司及全资孙公 司广州三电科技有限公司，公司将为前述公司提供总额不超过人民币 4.5 亿元的 担保额度，实际贷款及担保发生时，担保金额、担保期限、担保费率等内容，由 公司及相关子、孙公司与贷款银行等金融机构在以上额度内共同协商确定，相关 担保事项以正式签署的担保文件为准。 公司本次对外担保对象均为公司合并报表范围内的控股公司，无其他对外担 保。 二、被担保人基本情况 1、广州市金华大化学试剂有限公司 成立日期：1997 年 06 月 02 日 法定代表人：吴少斌 注册资本：5,000 万人民币 注册地址：广州市番禺区石楼镇创启路 63 号创启 4 号楼 经营范围：化工产品销售（不含许可类化工产品 ...

随着公司市场战略推进，公司海外业务市场规模不断扩大，外汇结算业务需 求逐步增加。为有效规避外汇市场风险，降低汇率对公司经营业绩的影响，开展 外汇衍生品业务。根据业务发展需要，本年度广东光华科技股份有限公司（以下 简称"公司"）及子公司拟开展总额不超过1,000万美元或等值外币的外汇衍生 品业务，自股东大会审议通过之日起12个月内可以循环滚动使用。 广东光华科技股份有限公司 关于开展外汇衍生品业务的可行性分析报告 一、开展远期结售汇业务的目的 二、开展外汇衍生品业务概述 1、投资金额：总金额不超过1,000万（含本数）美元或等值外币。 2、投资方式：公司开展的外汇衍生品交易品种均为与公司实际业务密切相 关的外汇衍生品，主要包括远期结售汇、外汇期权、掉期等产品或上述产品的组 合。该等外汇衍生品交易品种与公司业务在品种、规模、方向、期限、币种等方 面相互匹配。 3、投资期限：自本次股东大会审议通过之日起12个月内可以循环滚动使用。 4、资金来源：使用公司自有资金，不得使用募集资金直接或间接进行外汇 衍生品业务。 公司及子公司开展外汇衍生品交易业务遵循合法、谨慎、安全和有效的原则， 不做投机性、套利性的交易操作，但外 ...